44 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Xenetic Biosciences, Inc. XBIO shares climbed 163.6 percent to $6.3010.
• Ability Inc. ABIL gained 73.6 percent to $3.7490.
• AVROBIO, INC. AVRO shares rose 70.3 percent to $32.35. AVROBIO priced its 5.24 million share IPO at $19 per share.
• Stellar Biotechnologies, Inc. SBOT surged 37.6 percent to $2.27 after announcing encouraging results from a research study focused on the molecular composition of the company's KLH products. The company said the "study results demonstrated highly consistent molecular structure from batch to batch, a key attribute for a biologically sourced protein."
• TMSR Holding Company Limited TMSR rose 37.5 percent to $5.50.
• Heron Therapeutics, Inc. HRTX gained 32.1 percent to $40.55 after the company disclosed that HTX-011 for postoperative pain management has received Breakthrough Therapy designation from the FDA.
• Aptinyx Inc. APTX rose 22.5 percent to $19.59. Aptinyx priced its 6.4 million share IPO at $16 per share.
• Rhythm Pharmaceuticals, Inc. RYTM climbed 21.2 percent to $32.02 after announcing pricing of public offering.
• Barnes & Noble Education Inc BNED rose 20.3 percent to $8.13 following Q4 results.
• Xeris Pharmaceuticals Inc XERS climbed 19.1 percent to $17.86. Xeris Pharmaceuticals priced its 5.7 million share IPO at $15 per share.
• Boxlight Corporation BOXL gained 16.4 percent to $5.98 after the company announced a contract with Clayton County Schools to install mimio classroom solution suite in over 3,200 classrooms.
• BBVA Banco Francés S.A. BFR shares rose 14.9 percent to $15.71.
• Avalara, Inc. AVLR rose 14.5 percent to $51.55.
• China Advanced Construction Materials Group, Inc. CADC shares rose 13.1 percent to $4.75.
• Solid Biosciences Inc. SLDB gained 13 percent to $ 40.30.
• Darden Restaurants, Inc. DRI gained 11.8 percent to $104.31 after reporting upbeat earnings for its fourth quarter.
• Grupo Supervielle S.A. SUPV shares rose 11.5 percent to $15.27.
• CASI Pharmaceuticals, Inc. CASI shares gained 10.5 percent to $6.30. The biopharmaceutical said it secured a strategic and long-term manufacturing agreement with China's Yiling Wanzhou for manufacturing of entecavir and cilostazo, two FDA approved products for the treatment of chronic hepatitis B viral and intermittent claudication
• Aptevo Therapeutics Inc. APVO rose 10.2 percent to $5.65.
• Mesoblast Limited MESO gained 9.8 percent to $6.08. Mesoblast announced key Day 100 survival outcomes of Phase 3 trial for acute Graft Versus Host Disease
• Web.com Group Inc. WEB rose 9.3 percent to $25.35 after the company agreed to be acquired by an affiliate of Siris Capital Group, LLC for $25 per share in an all-cash deal valued at approximately $2 billion.
• Kroger Co. KR rose 9 percent to $28.54 after reporting upbeat results for its first quarter.
• Grupo Financiero Galicia S.A. GGAL climbed 8.4 percent to $42.03.
• Loma Negra Compañía Industrial Argentina Sociedad Anónima LOMA rose 7.2 percent to $12.86.
• ReneSola Ltd SOL gained 6.6 percent to $2.71. Roth Capital upgraded ReneSola from Sell to Neutral.
• Voyager Therapeutics Inc VYGR rose 4.5 percent to $22.13. The clinical-stage gene therapy company said the FDA granted a Regenerative Medicine Advanced Therapy (RMAT) designation for Voyager's VY-AADC gene therapy treatment for Parkinson's disease in patients with motor fluctuations.

Check out these big penny stock gainers and losers

Losers

• InVivo Therapeutics Holdings Corp. NVIV shares dipped 45.7 percent to $1.83 after reporting pricing of $13.2 million underwritten public offering.
• Gevo, Inc. GEVO fell 24.7 percent to $9.44 after dropping 35.74 percent on Wednesday.
• Forward Industries, Inc. FORD shares declined 20.9 percent to $1.74.
• Naked Brand Group Inc. NAKD shares dipped 20 percent to $6.80.
• CLPS Incorporation CLPS dropped 19.6 percent to $13.5001 after rising 56.13 percent on Wednesday.
• Caladrius Biosciences, Inc. CLBS shares dipped 18.3 percent to $7.0550.
• Veritone, Inc. VERI fell 16.2 percent to $18.11 after reporting a proposed public offering of common stock.
• YogaWorks, Inc. YOGA dropped 13.7 percent to $1.95.
• Moleculin Biotech, Inc. MBRX shares slipped 13.4 percent to $1.88. Moleculin reported a $2.3 million registered direct offering priced at-the-market.
• Alkermes plc ALKS fell 13.4 percent to $44.5001. Morgan Stanley downgraded Alkermes from Equal-Weight to Underweight.
• Golden Bull Limited DNJR shares tumbled 12.7 percent to $6.1101.
• Astrotech Corporation ASTC dropped 12.5 percent to $4.36.
• LiveXLive Media, Inc. LIVX dipped 11.2 percent to $9.260.
• Steelcase Inc. SCS fell 9.8 percent to $14.025 following Q1 results.
• Arbutus Biopharma Corporation ABUS shares fell 9 percent to $6.38.
• Neptune Technologies & Bioressources Inc. NEPT fell 8.3 percent to $4.08 after rising 37.77 percent on Wednesday.
• Syntel, Inc. SYNT shares fell 7.3 percent to $31.59. Wells Fargo downgraded Syntel from Market Perform to Underperform.
• Chegg, Inc. CHGG dropped 4.7 percent to $28.06. Jefferies downgraded Chegg from Buy to Hold.